Minerva Advisors LLC purchased a new stake in shares of Kura Oncology Inc. (NASDAQ:KURA) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 361,737 shares of the company’s stock, valued at approximately $977,000.
Separately, Alethea Capital Management LLC bought a new stake in shares of Kura Oncology during the second quarter valued at about $168,000. 43.63% of the stock is currently owned by hedge funds and other institutional investors.
Kura Oncology Inc. (NASDAQ:KURA) traded down 6.27% during trading on Friday, reaching $5.38. 67,163 shares of the company’s stock were exchanged. Kura Oncology Inc. has a 1-year low of $2.50 and a 1-year high of $25.00. The company’s 50-day moving average is $6.09 and its 200-day moving average is $4.14. The company’s market capitalization is $100.84 million.
Kura Oncology (NASDAQ:KURA) last issued its earnings results on Wednesday, August 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by $0.02. Equities research analysts expect that Kura Oncology Inc. will post ($1.58) earnings per share for the current fiscal year.
KURA has been the subject of several recent research reports. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $16.00 price target on shares of Kura Oncology in a report on Tuesday, June 21st. Zacks Investment Research raised shares of Kura Oncology from a “hold” rating to a “buy” rating and set a $3.75 price objective for the company in a research report on Wednesday, July 13th.
About Kura Oncology
Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.
Want to see what other hedge funds are holding KURA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kura Oncology Inc. (NASDAQ:KURA).
Receive News & Ratings for Kura Oncology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kura Oncology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.